A Pyrrole-Imidazole Polyamide Is Active against Enzalutamide-Resistant Prostate Cancer.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Cancer Research

• Publication date

  2017-05-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1158/0008-5472.CAN-16-2503PMID 28360139PMCID PMC5480898
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• RNA polymerase II senses obstruction in the DNA minor groove via a conserved sensor motif

  2016cited by this paper
• Divergent clonal evolution of castration resistant neuroendocrine prostate cancer

  2016cited by this paper
• Selectively targeting the DNA-binding domain of the androgen receptor as a prospective therapy for prostate cancer.

  2015cited by this paper
• Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer

  2015cited by this paper
• The Evolutionary History of Lethal Metastatic Prostate Cancer

  2015cited by this paper
• Enzalutamide in metastatic prostate cancer before chemotherapy.

  2014cited by this paper
• Therapeutic Targeting of BET Bromodomain Proteins in Castration-Resistant Prostate Cancer

  2014cited by this paper
• Small Molecule BMH-Compounds That Inhibit RNA Polymerase I and Cause Nucleolar Stress

  2014cited by this paper
• Biologic and clinical significance of androgen receptor variants in castration resistant prostate cancer.

  2014cited by this paper
• Selectively Targeting the DNA-binding Domain of the Androgen Receptor as a Prospective Therapy for Prostate Cancer*

  2014cited by this paper
• Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade.

  2013influential reference
• Antitumor activity of a pyrrole-imidazole polyamide

  2013cited by this paper
• Animal Toxicity of Hairpin Pyrrole-Imidazole Polyamides Varies with the Turn Unit

  2013cited by this paper
• An androgen receptor N-terminal domain antagonist for treating prostate cancer.

  2013cited by this paper
• DNA Binding Site Sequence Directs Glucocorticoid Receptor Structure and Activity

  2009cited by this paper
• Allosteric modulation of DNA by small molecules

  2009cited by this paper
• A phase II study of mifepristone (RU‐486) in castration‐resistant prostate cancer, with a correlative assessment of androgen‐related hormones

  2008cited by this paper
• Suppression of androgen receptor-mediated gene expression by a sequence-specific DNA-binding polyamide

  2007cited by this paper
• Molecular determinants of resistance to antiandrogen therapy

  2004cited by this paper
• Recognition of the DNA minor groove by pyrrole-imidazole polyamides.

  2003cited by this paper

• Emerging Therapeutic Approaches to Engage the Androgen Receptor for the Treatment of Castration-Resistant Prostate Cancer

  2025cites this paper
• Novel therapeutic strategy targeting STMN1 using chlorambucil‐conjugated pyrrole–imidazole polyamide in small cell lung cancer

  2025cites this paper
• Untargeted Multiomics of LNCaP Cell Line Treated with a Novel DNA Minor Groove Binder and/or Doxorubicin Using Mass Spectrometry.

  2025cites this paper
• Chemical Control of Genes: Synthetic Genome Readers and Gene Regulators.

  2025cites this paper
• Antitumor efficacy of a sequence-specific DNA-targeted γPNA-based c-Myc inhibitor

  2024cites this paper
• Design and Synthesis of Dual-Target Inhibitors Targeting Androgen Receptors and Glucocorticoid Receptors to Overcome Antiandrogen Resistance in Castration-Resistant Prostate Cancer.

  2024cites this paper
• Androgen receptor inhibitors in treating prostate cancer

  2024cites this paper
• Sequence-Selective Recognition of the d(GGCGCC)2 DNA Palindrome by Oligopeptide Derivatives of Mitoxantrone. Enabling for Simultaneous Targeting of the Two Guanine Bases Upstream from the Central Intercalation Site in Both Grooves and along Both Strands

  2024cites this paper
• Spectroscopic, biochemical and computational studies of bioactive DNA minor groove binders targeting 5'-WGWWCW-3' motif.

  2024cites this paper
• Current and emerging approaches to noncompetitive AR inhibition

  2023cites this paper
• Targeting HIF-1 for prostate cancer: a synthesis of preclinical evidence

  2023cites this paper
• Nucleic acids as templates and catalysts in chemical reactions: target-guided dynamic combinatorial chemistry and in situ click chemistry and DNA/RNA induced enantioselective reactions.

  2023cites this paper
• DeepAR: a novel deep learning-based hybrid framework for the interpretable prediction of androgen receptor antagonists

  2023cites this paper
• DNA binding, Cleavage, Catalytic, Magnetic Active; 2,2–bipyridyl based d-f hetero binuclear Gd(III), Cu(II) Complexes and Their Electrochemical, Fluorescence Studies

  2023cites this paper
• RNA polymerase II trapped on a molecular treadmill: Structural basis of persistent transcriptional arrest by a minor groove DNA binder

  2022cites this paper
• Potentiometric Determination of Acid Dissociation Constants (pK a) for an Anticancer Pyrrole-Imidazole Polyamide.

  2022cites this paper
• Novel Pyridazin-3(2H)-one-Based Guanidine Derivatives as Potential DNA Minor Groove Binders with Anticancer Activity

  2022cites this paper
• Principles of small molecule–DNA recognition

  2022cites this paper
• Genome-wide crosstalk between steroid receptors in breast and prostate cancers

  2021cites this paper
• Mitochondria: Endosymbiont bacteria DNA sequence as a target against cancer

  2021cites this paper
• Development of novel androgen receptor inhibitors to overcome castrate-resistant prostate cancer

  2021cites this paper
• PIP–HoGu, an Artificial Assembly with Cooperative DNA Recognition

  2020cites this paper
• Recent advances in β-lactam derivatives as potential anticancer agents.

  2020cites this paper
• DNA-BINDING and DNA-protecting activities of small natural organic molecules and food extracts.

  2020cites this paper
• Artificial Assemblies with Cooperative DNA Recognition

  2020cites this paper
• Synthetic DNA Binding Assembly: Architecture, Application and Perspectives

  2020cites this paper
• Single position substitution of hairpin pyrrole-imidazole polyamides imparts distinct DNA-binding profiles across the human genome

  2020cites this paper
• Design, synthesis and anti-cancer activity of pyrrole-imidazole polyamides through target-downregulation of c-kit gene expression.

  2020cites this paper
• Mechanisms of enzalutamide resistance in castration‐resistant prostate cancer and therapeutic strategies to overcome it

  2020cites this paper
• Targeting the mutant PIK3CA gene by DNA‐alkylating pyrrole‐imidazole polyamide in cervical cancer

  2020cites this paper
• Modulation of nuclear receptor function: Targeting the protein-DNA interface.

  2019cites this paper
• An investigation of the factors that dictate the preferred orientation of lexitropsins in the minor groove of DNA.

  2019cites this paper
• Recent developments in compounds acting in the DNA minor groove.

  2019cites this paper
• Introduction: Sequence-Specific DNA Binding Pyrrole–Imidazole Polyamides and Their Applications

  2019cites this paper
• Sequence specific suppression of androgen receptor–DNA binding in vivo by a Py-Im polyamide

  2019influential citation
• Rational drug design for androgen receptor and glucocorticoids receptor dual antagonist.

  2019cites this paper
• Structural and Kinetic Profiling of Allosteric Modulation of Duplex DNA Induced by DNA‐Binding Polyamide Analogues

  2019cites this paper
• Therapeutic gene regulation using pyrrole-imidazole polyamides.

  2019cites this paper
• Deep eutectic solvent promoted synthesis of structurally diverse hybrid molecules with privileged heterocyclic substructures

  2019cites this paper
• Sequence-specific DNA binding Pyrrole-imidazole polyamides and their applications.

  2018cites this paper
• Delineation of the androgen‐regulated signaling pathways in prostate cancer facilitates the development of novel therapeutic approaches

  2018cites this paper
• The potential of AR-V7 as a therapeutic target

  2018cites this paper
• Pip-HoGu: An Artificial Assembly with Cooperative DNA Recognition Capable of Mimicking Transcription Factor Pairs.

  2018cites this paper
• Direct Targeting of MYCN Gene Amplification by Site-Specific DNA Alkylation in Neuroblastoma.

  2018cites this paper
• Molecules targeting the androgen receptor (AR) signaling axis beyond the AR‐Ligand binding domain

  2018cites this paper
• New Generation of Selective Androgen Receptor Degraders: Our Initial Design, Synthesis, and Biological Evaluation of New Compounds with Enzalutamide-Resistant Prostate Cancer Activity.

  2018cites this paper
• Interplay between hypoxia and androgen controls a metabolic switch conferring resistance to androgen/AR-targeted therapy

  2018cites this paper
• Thermodynamics of DNA Minor Groove Binders.

  2018cites this paper
• Tagalide A and tagalol A, naturally occurring 5/6/6/6- and 5/6/6-fused cyclic dolabrane-type diterpenes: a new insight into the anti-breast cancer activity of the dolabrane scaffold

  2018cites this paper
• Programmable pyrrole-imidazole polyamides: A potent tool for DNA targeting

  2018cites this paper
• Mechanistic studies of a small-molecule modulator of SMN2 splicing

  2018cites this paper
• An overview of recent advances in duplex DNA recognition by small molecules

  2018cites this paper
• Interference with DNA repair after ionizing radiation by a pyrrole-imidazole polyamide

  2018cites this paper
• Scaffold diversity-oriented synthesis of limonoid dimers: discovery of an axially chiral agent with in vivo anti-breast cancer activity

  2018cites this paper
• Prostate cancer: Targeting the core of resistance

  2017cites this paper
• Molecular Mechanisms of Enzalutamide Resistance in Prostate Cancer

  2017cites this paper
• The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy

  2017cites this paper
• A computational protocol for the discovery of lead molecules targeting DNA unique to pathogens.

  2017cites this paper
• Structural basis of DNA duplex distortion induced by thiazole-containing hairpin polyamides

  2017cites this paper